In the irritable bowel syndrome (IBS) model, EA at ST36 has been found to decrease the level of mast cells (MC) and downregulate interleukin-1β (IL-1β) in colon tissue, thus improving visceral hypersensitivity (Wang et al., 2019). The gene discussed is IL1B; the disease is irritable bowel syndrome.